Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Borderline ovarian tumors

C J Link1, E Reed, G Sarosy

  • 1Human Gene Therapy Research Institute, Central Iowa Health Systems, Des Moines 50325, USA.

The American Journal of Medicine
|August 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated assessment of the effects of PFOA exposure on hepatic transcriptome and lipid profiles in mice expressing human PPARα.

Toxicology and applied pharmacology·2025
Same author

Creating work environments where people of all genders in gynecologic oncology can thrive: An SGO evidence-based review.

Gynecologic oncology·2022
Same author

A new mechanism for void-cascade interaction from nondestructive depth-resolved atomic-scale measurements of ion irradiation-induced defects in Fe.

Science advances·2020
Same author

Overall survival and updated progression-free survival outcomes in a randomized phase II study of combination cediranib and olaparib versus olaparib in relapsed platinum-sensitive ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2019
Same author

Multi-level Determinants of Clinic Attendance and Antiretroviral Treatment Adherence Among Fishermen Living with HIV/AIDS in Communities on Lake Victoria, Uganda.

AIDS and behavior·2018
Same author

The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications.

Annals of oncology : official journal of the European Society for Medical Oncology·2017
Same journal

Mineralocorticoid Antagonists for Post-MI HFpEF: Plausible Biology Meets Low Residual Risk?

The American journal of medicine·2026
Same journal

GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

The American journal of medicine·2026
Same journal

Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

The American journal of medicine·2026
Same journal

Cave Canem - Beware of the Dog.

The American journal of medicine·2026
Same journal

Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

The American journal of medicine·2026
Same journal

Mesenteric panniculitis.

The American journal of medicine·2026
See all related articles

Borderline tumors of the ovary (BOT) are epithelial tumors with a better prognosis than ovarian cancer. Long-term follow-up is crucial as recurrence can occur years later, and adjuvant therapy effectiveness for advanced disease remains undetermined.

Area of Science:

  • Gynecologic Oncology
  • Pathology
  • Surgical Oncology

Background:

  • Borderline tumors of the ovary (BOT) are epithelial ovarian tumors characterized by low growth and invasion potential.
  • BOT generally has a better prognosis than epithelial ovarian cancer, though stage III lesions with peritoneal implants occur.
  • Long-term follow-up is essential due to the potential for recurrence up to 20 years post-diagnosis.

Purpose of the Study:

  • To review the characteristics, prognosis, and management of borderline tumors of the ovary.
  • To identify subsets of patients with a worse prognosis, such as those with aneuploid tumors.
  • To discuss current treatment strategies and the unresolved role of adjuvant therapy in advanced disease.

Main Methods:

  • Literature review and synthesis of existing studies on ovarian borderline tumors.

Related Experiment Videos

  • Analysis of prognostic factors, including tumor stage and ploidy.
  • Evaluation of surgical and adjuvant treatment approaches for early and advanced stages.

    • Main Results:

    • Early-stage BOT generally has an excellent prognosis with conservative surgery preserving fertility.
    • Higher stage lesions and aneuploid tumors are associated with a worse prognosis.
    • Adjuvant therapy for advanced BOT has yielded conflicting results, with its utility remaining undetermined.

    Conclusions:

    • Ovarian borderline tumors require long-term surveillance due to recurrence risk.
    • Conservative surgery is effective for early-stage disease, particularly in women desiring fertility.
    • Further research into high-risk subsets may guide future adjuvant therapy trials for advanced BOT.